KR20080107924A - Manufacturing method of red ginseng concentrate - Google Patents
Manufacturing method of red ginseng concentrate Download PDFInfo
- Publication number
- KR20080107924A KR20080107924A KR1020070056322A KR20070056322A KR20080107924A KR 20080107924 A KR20080107924 A KR 20080107924A KR 1020070056322 A KR1020070056322 A KR 1020070056322A KR 20070056322 A KR20070056322 A KR 20070056322A KR 20080107924 A KR20080107924 A KR 20080107924A
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- ginseng
- hours
- concentrate
- red
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 홍삼 농축액의 제조방법에 관한 것으로, 특히 인삼을 이용한 홍삼 농축액의 제조방법, 상기 제조방법에 의해 제조된 홍삼 농축액 및 이를 이용한 홍삼 관련 제품에 관한 것이다. 본 발명에 따른 홍삼 농축액의 제조방법은 조사포닌 함량이 우수한 홍삼 농축액을 제조할 수 있게 한다. 따라서, 본 발명의 제조방법에 의해 제조된 홍삼 농축액은 효능이 뛰어난 홍삼 관련 제품을 제조할 수 있게 할 뿐만 아니라 상황 버섯, 동충하초와 더불어 우수한 홍삼 관련 제품의 제조에 이용될 수 있다.The present invention relates to a method for preparing red ginseng concentrate, and in particular, to a method for producing red ginseng concentrate using ginseng, a red ginseng concentrate prepared by the method and a red ginseng related product using the same. The manufacturing method of the red ginseng concentrate according to the present invention enables the preparation of the red ginseng concentrate having an excellent content of irradiated phononine. Therefore, the red ginseng concentrate prepared by the manufacturing method of the present invention can be used not only to produce a red ginseng-related product having excellent efficacy, but also to prepare excellent red ginseng-related products along with mushrooms and cordyceps.
Description
도 1은 증숙 시간에 따른 홍삼의 색택 변화를 나타낸 것이다.Figure 1 shows the color change of red ginseng according to the steaming time.
본 발명은 홍삼 농축액의 제조방법에 관한 것으로, 특히 인삼을 이용한 홍삼 농축액의 제조방법, 상기 제조방법에 의해 제조된 홍삼 농축액 및 이를 이용한 홍삼 관련 제품에 관한 것이다.The present invention relates to a method for preparing red ginseng concentrate, and in particular, to a method for producing red ginseng concentrate using ginseng, a red ginseng concentrate prepared by the method and a red ginseng related product using the same.
인삼(Panax ginseng C.A. Meyer)은 오갈피나무과(Araliceae) 인삼속(Panax)에 속하는 다년생 초본류로서, 한의학에서는 기허에 주로 사용되는 가장 중요한 보기약으로 다루어지고 있으며, 강장(强壯), 강정(强精), 조혈(造血), 보온(保溫), 피로회복, 정신안정, 진정작용 등의 효능이 있는 것으로 알려져 있어, 폭넓게 약용으로 사용되고 있다. Panax ginseng CA Meyer is a perennial herb belonging to the genus Araliceae Panax ginseng, and is regarded as the most important herbal medicine used in the Chinese medicine in tonic, gangjeong and gangjeong. It is known to have the effects of hematopoiesis, heat retention, fatigue recovery, mental stability, sedation, and is widely used for medicinal purposes.
인삼에는 사포닌 성분, 정유성분, 식물스테롤, 폴리아세틸렌, 페놀성 물질과 같은 지용성 성분, 다당체 성분 등과 같이 주요 효능성분을 함유하고 있는데, 이러한 인삼의 효능은 주로 인삼사포닌(ginsenoside)에 의한 것으로 이에 대한 연구가 많이 이루어지고 있다. 인삼 사포닌은 트리터펜(triterpene)인 비당부(protopanaxadiol과 protopananatriol)의 R1, R2, R3의 알콜성 OH기에 글루코스, 람노스, 자일로스, 아라비노스와 같은 당류가 에테르 결합을 하여 구성되며, 현재까지 30종이상의 인삼 사포닌이 밝혀져 있으며, 화학 구조의 특성에 따라 프로토파낙사디올(Protopanaxadiol)계(19종), 프로토파낙사트리올(Protopanaxatriol)계(10종) 및 올레안(Oleanane)계(1종) 사포닌으로 구분된다. Ginseng contains major potency components such as saponin, essential oils, phytosterols, polyacetylene, and fat-soluble components such as phenolic substances, and polysaccharides. The effects of ginseng are mainly due to ginseng saponins (ginsenoside). A lot of research is being done. Ginseng saponins are composed of ether-bonded sugars such as glucose, rhamnose, xylose and arabinose in the alcoholic OH groups of R1, R2 and R3 of triterpene, protopanaxadiol and protopananatriol. More than 30 kinds of ginseng saponins have been identified, and according to the characteristics of the chemical structure, Protopanaxadiol (19 species), Protopanaxatriol (10 species) and Oleanane (1) Species) saponins.
이러한 인삼 사포닌은 다른 식물들과 달리 독성이 없고, 항암작용, 항당뇨작용, 중추신경 억제작용, 동맥경화 및 고혈압의 예방, 간기능 촉진 및 숙취제거효과, 항피로 및 항스트레스 작용, 항산화작용, 항염활성, 단백질합성 촉진 작용, 면역증강작용 등이 알려져 있다. This ginseng saponin is not toxic unlike other plants, and is anti-cancer, anti-diabetic, central nervous system, arteriosclerosis and hypertension prevention, liver function and hangover removal, anti-fatigue and anti-stress, antioxidant, Anti-inflammatory activity, protein synthesis promoting action, immune enhancing action and the like are known.
사포닌 중에는 수삼을 증숙 및 건조과정을 거쳐 제조되는 홍삼에만 특유하게 존재하는 사포닌이 있는 데, 이러한 홍삼에 소량 존재하는 진세노사이드 Rg2, Rg3, Rh1, Rh2, Rs3와 같은 특유성분이 암예방작용, 암세포성장 억제작용, 혈압강하 작용, 뇌신경세포 보호작용, 항혈전작용, 항산화작용 등에 뛰어난 효과가 있다는 점이 밝혀져 홍삼만이 가지는 장점으로 주목받고 있다. Among saponins, saponins which are unique to red ginseng are produced by steaming and drying ginseng, and they are unique ingredients such as ginsenosides Rg 2 , Rg 3 , Rh 1 , Rh 2 , and Rs 3 which are present in small amounts in red ginseng. This cancer prevention, cancer cell growth inhibitory effect, blood pressure lowering action, neuroprotective neuroprotective action, anti-thrombotic action, antioxidant activity has been found to be attracting attention as the advantage that only red ginseng has.
최근에는 이와 같이 다양한 질병에 대해 우수한 효과를 나타내는 인삼 사포닌 성분을 섭취하기 위해 다양한 식품들이 개발되고 있으며, 특히 생활 수준의 향상 및 건강 식품에 대한 소비자들의 욕구 증대로 인해 앞으로 홍삼 관련 제품들의 수요는 더욱 증가할 전망이다.In recent years, various foods have been developed to consume ginseng saponin, which has excellent effects on various diseases, and in particular, demand for red ginseng-related products is expected to increase due to improved living standards and increased consumer desire for health foods. It is expected to increase.
이에 본 발명자들은 우수한 품질의 홍삼 관련 제품을 개발하기 위해 연구를 수행하던 중 조사포닌 함량이 우수한 홍삼 추출물의 제조방법을 개발하고, 이를 이용하여 홍삼 추출물 및 홍삼관련 제품을 제조함으로써 본 발명을 완성하였다.Accordingly, the present inventors have developed a method for producing red ginseng extract with excellent irradiated poinin content while conducting research to develop red ginseng-related products of excellent quality, and completed the present invention by manufacturing red ginseng extract and red ginseng related products using the same. .
따라서, 본 발명의 목적은 홍삼 추출물의 제조방법을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a method for preparing red ginseng extract.
상기 목적을 달성하기 위하여 본 발명은 홍삼 추출물의 제조방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing red ginseng extract.
본 발명의 다른 목적을 달성하기 위하여, 본 발명은 상기 제조방법에 의해 제조된 홍삼 추출물을 제공한다.In order to achieve another object of the present invention, the present invention provides a red ginseng extract prepared by the above production method.
본 발명의 또 다른 목적을 달성하기 위하여, 본 발명은 상기 홍삼 추출물을 포함하는 홍삼 제품을 제공한다.In order to achieve another object of the present invention, the present invention provides a red ginseng product comprising the red ginseng extract.
이하, 본 발명을 더욱 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in more detail.
본 발명의 홍삼 농축액의 제조방법은 인삼을 증숙, 1차건조, 2차건조, 홍삼 추출 및 농축하는 단계를 포함하는 것을 특징으로 한다. The manufacturing method of the red ginseng concentrate of the present invention is characterized by comprising the steps of steaming, primary drying, secondary drying, red ginseng extraction and concentration.
본 발명의 홍삼 농축액의 제조방법을 보다 상세히 설명하면, 다음과 같다.The red ginseng concentrate of the present invention will be described in detail below.
즉, 본 발명의 홍삼 농축액의 제조방법은That is, the manufacturing method of the red ginseng concentrate of the present invention
(a) 인삼을 94 내지 96℃에서 5 내지 8시간동안 증숙하는 단계;(a) steaming ginseng at 94-96 ° C. for 5-8 hours;
(b) 상기 (a) 단계에서 증숙된 인삼을 65 내지 75℃에서 18 내지 36시간동안 1차건조하는 단계;(b) first drying the ginseng steamed in step (a) at 65 to 75 ° C. for 18 to 36 hours;
(c) 상기 (b) 단계에서 건조된 인삼을 45 내지 55℃에서 48 내지 96시간동안 2차건조하여 홍삼을 제조하는 단계;(c) preparing red ginseng by secondary drying the ginseng dried in step (b) for 48 to 96 hours at 45 to 55 ° C;
(d) 상기 (c) 단계에서 제조된 홍삼을 15 내지 25배의 정제수에 넣고 94 내지 96℃에서 18 내지 36시간동안 가열하여 추출하는 단계; 및(d) extracting the red ginseng prepared in step (c) into 15-25 times purified water and heating by heating at 94-96 ° C. for 18-36 hours; And
(e) 상기 (d) 단계에서의 추출액을 농축하는 단계를 포함한다.(e) concentrating the extract in step (d).
본 발명의 제조방법에 사용되는 인삼은 종류 및 원산지 등으로 특별히 한정되지 않는다. 예를 들어, 상기 인삼은 인삼(Panax ginseng C.A. Meyer), 화기삼 (Panax quinquefolium), 전칠삼 (Panax notoginseng), 죽절삼 (Panax japonicum), 삼엽삼 (Panax trifolium) 및 히말라야삼 (Panax pseudoginseng)일 수 있다. Ginseng used in the production method of the present invention is not particularly limited to the type and origin. For example, the ginseng is Panax ginseng CA Meyer, Panax ginseng quinquefolium), jeonchilsam (Panax notoginseng), jukjeol three (Panax japonicum ), Trilobite ( Panax trifolium ) and Himalayan ginseng ( Panax pseudoginseng ).
상기 (a) 단계의 증숙은 당업계에 공지된 통상적인 방법, 예를 들면, 이물이 혼입되지 않도록 물로 잘 세척한 인삼을 증숙기에 서로 눌리거나 겹치지 않도록 배치한 다음 가열하여 증숙시킬 수 있다. 증숙은 94 내지 96℃에서 5 내지 8시간동안 수행하며, 94℃ 미만의 온도에서 또는 5시간 미만의 시간동안 증숙하는 경우 증숙이 충분치 않아 조사포닌 함량이 적게 되며, 96℃ 이상의 온도에서 또는 8시간 이상의 시간동안 증숙하는 경우 증숙이 과도하게 되어 조사포닌 함량이 감소하여 적절하지 않다. 한편, 증숙된 인삼을 건조시키기 전에 증숙기의 압력을 낮추는 데, 갑자기 압력을 낮추게 되면, 삼의 몸체가 대부분이 터지게 되므로 증숙기에서 스팀을 서서히 배출시키거나 압력이 상압이 될 때까지 방치한다.Steaming in step (a) may be performed by conventional methods known in the art, for example, by placing ginseng well-washed with water so as not to be mixed with foreign materials, so as not to be pressed or overlap with each other in the steamer, and then heating it. Steaming is carried out at 94-96 ° C. for 5-8 hours, and when steaming at a temperature below 94 ° C. or for less than 5 hours, the vaporization is not sufficient, resulting in low irrelevant irradiated saponin, at temperatures above 96 ° C. or 8 hours. When steaming for more than this time, steaming becomes excessive and the irrelevant amount of irradiated ponin is not appropriate. On the other hand, before drying the steamed ginseng to lower the pressure of the steamer, suddenly lower the pressure, the body of the ginseng will burst most of the steam from the steamer or left until the pressure is normal pressure.
상기 (b) 단계의 1차건조는 통상의 건조기에서 증숙된 인삼을 65 내지 75℃에서 18 내지 36시간동안 수행된다. 바람직하게는 열풍건조기에서 70℃, 24시간의 조건으로 건조시킬 수 있다. 1차건조를 통해 인삼의 표면이 건조되고 이 표면이 차폐막의 역할을 하여 유용한 휘발성분의 휘발을 상당부분 막을 수 있게 된다.The primary drying of step (b) is carried out for 18 to 36 hours at 65 to 75 ℃ steamed ginseng in a conventional dryer. Preferably it can be dried in a hot air dryer under the conditions of 70 ℃, 24 hours. The primary drying causes the surface of ginseng to dry, and this surface acts as a shielding membrane, preventing much of the volatilization of useful volatiles.
상기 (c) 단계의 2차건조는 통상의 건조기에서 45 내지 55℃에서 48 내지 96시간동안 건조하여 수행한다. 바람직하게는 열풍건조기에서 50℃, 72시간의 조건으로 건조시킬 수 있으며, 2차건조를 통해 홍삼이 제조되게 된다.The secondary drying of step (c) is carried out by drying for 48 to 96 hours at 45 to 55 ℃ in a conventional dryer. Preferably, the hot air dryer can be dried under the conditions of 50 ° C. and 72 hours, and red ginseng is prepared through secondary drying.
상기 (d) 단계의 추출은 당업계에 공지된 열수추출방법에 의할 수 있으며, 예를 들어 제조된 홍삼을 15 내지 25배의 정제수에 넣고 94 내지 96℃에서 18 내지 36시간동안 가열하여 수행된다. Extraction of the step (d) may be by a hot water extraction method known in the art, for example, the red ginseng prepared in 15 to 25 times purified water and performed by heating at 94 to 96 ℃ for 18 to 36 hours do.
(e) 단계의 추출액의 농축은 보관 및 제품화의 용이를 위하여 당업계에 공지된 통상적인 농축방법, 예를 들면, 진공농축, 가열농축, 냉동농축방법 등에 의할 수 있다.Concentration of the extract of step (e) may be by conventional concentration methods known in the art for ease of storage and commercialization, such as vacuum concentration, heating concentration, freeze concentration method and the like.
본 발명의 실험예에서는 증숙온도 및 증숙시간을 달리하여 각각의 조건에 따른 조사포닌 함량을 측정하였다. 그 결과 94 내지 96℃의 온도 및 5 내지 8시간의 시간동안 증숙한 인삼이 조사포닌 함량이 우수하여 효능이 우수한 제품을 만들 수 있음을 알 수 있었다. 이에 본 발명의 일 실시예에서는 상기 결과를 바탕으로 하여 홍삼 농축액을 제조하였다.In the experimental example of the present invention by varying the steaming temperature and steaming time, the content of irradiated ponponin according to each condition was measured. As a result, it was found that ginseng steamed at a temperature of 94 to 96 ° C. and a time of 5 to 8 hours has an excellent content of irradiated phononine to make a product having excellent efficacy. In one embodiment of the present invention to prepare a red ginseng concentrate based on the above results.
따라서, 본 발명의 홍삼 농축액의 제조방법은 조사포닌 함량이 많은 홍삼 농축액을 제조할 수 있다. 아울러, 상기 홍삼 농축액을 상황버섯, 동충하초 및 산미료, 기능성원료, 보존료, 조미료, 착색료, 비타민와 같은 첨가물과 더불어 공지의 과립차 제조방법, 캅셀 또는 타블렛 제조방법 및 드링크 제조방법에 적용하여 과립차, 캅셀, 타블렛 및 드링크와 같은 홍삼 제품을 제조할 수 있다.Therefore, the method for preparing a red ginseng concentrate of the present invention can produce a red ginseng concentrate having a high content of irradiated ponin. In addition, the red ginseng concentrate is applied to known granular tea manufacturing method, capsule or tablet manufacturing method and drink manufacturing method together with additives such as green mushrooms, cordyceps and acidulants, functional ingredients, preservatives, seasonings, coloring agents, vitamins, and granule tea, capsules, tablets. And red ginseng products such as drinks.
이하. 본 발명을 실시예에 의해 상세히 설명한다.Below. The present invention will be described in detail by way of examples.
단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.However, the following examples are merely to illustrate the invention, but the content of the present invention is not limited to the following examples.
<< 실험예Experimental Example 1> 1>
홍삼농축액 제조 조건에 따른 영향 비교Comparison of Effects of Red Ginseng Concentrate on Manufacturing Conditions
<1-1> <1-1> 증숙Steaming 온도에 따른 영향 비교 Comparison of effects of temperature
인삼(5년근 풍기인삼)을 물로 세척한 다음 세척한 인삼을 채반에 서로 눌리거나 겹치지 않도록 올려놓고, 상압에서 온도를 달리하여(90℃, 92℃, 94℃, 96℃ 및 98℃) 3시간 동안 증숙하였다. 증숙 후 압력을 서서히 낮추어 상압과 같아지도록 하고, 이를 실온까지 서서히 냉각하였다. 이를 70℃의 열풍건조기에서 24시간 동안 1차 건조하고, 다시 50℃의 열풍건조기에서 72시간 동안 2차 건조를 실시하였다. 잘 건조된 홍삼은 곱게 마쇄하여 실험에 사용할 때까지 냉동 보관하였다.Ginseng (5 years old Punggi Ginseng) was washed with water, and the washed ginseng was placed on the tray so as not to be pressed or overlapped with each other, and the temperature was changed at normal pressure (90 ℃, 92 ℃, 94 ℃, 96 ℃ and 98 ℃) for 3 hours. Steamed for a while. After steaming, the pressure was slowly lowered to equal the atmospheric pressure, which was slowly cooled to room temperature. This was first dried for 24 hours in a 70 ° C hot air dryer, and again subjected to secondary drying for 72 hours in a 50 ° C hot air dryer. The well dried red ginseng was finely ground and stored frozen until used in the experiment.
각각의 증숙 온도에 따른 홍삼의 조사포닌 함량은 식품공전에 기재되어 있는 홍삼 성분 실험법에 따라 수행하였다. 이를 간략히 설명하면, 먼저 곱게 마쇄한 각각의 시료 10g을 정밀히 달아 삼각플라스크에 넣고 메탄올 100㎖을 가하여 1시간씩 2회 교반 추출한 후 여과하였다. 다시 50㎖ 메탄올로 여지상의 잔사를 씻고 여액을 합쳐 수욕(water bath) 중에서 감압 농축하였다. 농축 잔류물을 물 50㎖에 용해시 키고 분액깔때기에 옮겨 물포화부탄올 50㎖로 3회 추출해 주었다. 추출액을 모두 합쳐서 분액깔때기에 옮겨 넣은 후 물 50㎖로 세척한 후 물과 부탄올층을 완전히 분리시켜 미리 함량된 농축 플라스크에 옮겨 수욕 중에서 감압 농축하여 부탄올을 제거하여 주었다. 농축잔류물에 에테르 50㎖을 넣어주고 환류냉각기를 붙여 수욕 중에서 36℃로 30분간 탈지시켜준 후 에테르를 제거하여 주었다. 잔류물은 105℃에서 20분간 건조하고 다시 데시케이터에서 30분간 냉각시킨 후 무게를 측정하여 조사포닌 함량을 구하였다. The irradiated ponsonine content of red ginseng according to the steaming temperature was performed according to the red ginseng component test method described in the Food Code. Briefly, first, 10 g of each finely ground sample was precisely weighed, placed in an Erlenmeyer flask, and 100 ml of methanol was added thereto, stirred and extracted twice for 1 hour, and then filtered. The filtrate residue was washed again with 50 ml methanol and the filtrates were combined and concentrated under reduced pressure in a water bath. The concentrated residue was dissolved in 50 ml of water and transferred to a separatory funnel and extracted three times with 50 ml of saturated butanol. The combined extracts were transferred to a separatory funnel, washed with 50 ml of water, and the water and butanol layers were completely separated, transferred to a concentrated flask, and concentrated under reduced pressure in a water bath to remove butanol. 50 ml of ether was added to the concentrated residue, and a reflux condenser was added to remove the ether after degreasing at 36 ° C. for 30 minutes in a water bath. The residue was dried at 105 ° C. for 20 minutes, cooled again in a desiccator for 30 minutes, and weighed to determine the content of the irradiated phonyponin.
그 결과, 하기 표 1과 같이 증숙온도별 조사포닌 함량은 90℃에서 4.8%, 92℃에서 5.5%, 94℃에서 5.9%, 96℃에서 5.8%, 그리고 98℃에서는 5.5%로 나타났다. 아울러, 증숙한 홍삼의 색택은 90℃와 92℃로 처리한 경우는 색깔의 변화가 적었으며, 94℃와 96℃에서는 홍삼의 고유한 색택을 띄었으나 98℃이상의 경우는 홍삼의 색깔이 흑갈색으로 변화하는 것으로 나타났다. 따라서 94 내지 96℃에서 증숙한 홍삼의 조사포닌 함량이 가장 높게 나타나고, 홍삼의 색택이 가장 양호한 결과를 바탕으로 94 내지 96℃에서의 홍삼제조가 유리할 것으로 판단되었다.As a result, as shown in Table 1, the irradiation-ponin content for each steaming temperature was 4.8% at 90 ° C, 5.5% at 92 ° C, 5.9% at 94 ° C, 5.8% at 96 ° C, and 5.5% at 98 ° C. In addition, the color of steamed red ginseng showed little change of color when treated at 90 ℃ and 92 ℃, and the color of red ginseng was dark brown at 94 ℃ and 96 ℃, but the color of red ginseng was higher than 98 ℃. It appeared to change. Therefore, red ginseng steamed at 94-96 ° C. showed the highest content, and red ginseng at 94-96 ° C. would be advantageous based on the best results.
<1-2> <1-2> 증숙Steaming 시간에 따른 영향 비교 Compare effects over time
증숙 시간의 영향을 알아보기 위해, 94℃의 온도조건에서 증숙시간을 달리하여(1시간, 2시간, 3시간, 4시간, 5시간, 6시간, 7시간, 8시간 및 10시간) 홍삼의 색택과 조사포닌 함량을 측정하였다. 조사포닌 함량 측정은 상기 실험예 <1-1>에서와 같은 방법으로 측정하였다.To determine the effect of steaming time, different steaming times (1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours and 10 hours) at 94 ℃ Color and irradiated phononine content was measured. Irradiation content was measured in the same manner as in Experimental Example <1-1>.
그 결과, 홍삼의 색택은 도 1에서와 같이 증숙 시간이 경과할수록 증숙한 삼의 색택이 갈색으로 변화되는 것을 알 수 있었으며, 4시간이후부터는 홍삼 특유의 갈색을 나타내며, 10시간이후에는 갈색을 넘어 흑갈색을 나타내게 됨을 알 수 있었다.As a result, the color of red ginseng was changed to brown color of steamed ginseng as the steaming time elapsed as shown in FIG. 1, and after 4 hours, the color of red ginseng was brown, and after 10 hours, the color of brown was exceeded. It turned out to be dark brown.
증삼 시간별 조사포닌 함량은 하기 표 2에서와 같이 6시간 증삼 시 최대에 이르는 것으로 나타났으며, 그 이후에는 오히려 조사포닌의 함량이 낮아지는 것을 알 수 있었다. 이와 같은 결과를 볼 때 조사포닌의 함량으로 볼 때 증숙시간은 5시간 내지 8시간정도 바람직함을 알 수 있었다.The amount of irradiated ginseng per hour was shown to reach the maximum at 6 hours of red ginseng, as shown in Table 2 below, after which the content of irradiated ginseng was lowered. From the results, it was found that the steaming time is preferably about 5 hours to 8 hours in view of the content of the irradiated phononine.
상기의 결과로부터 홍삼의 증삼을 위한 온도는 94 내지 96℃가, 증삼 시간은 5시간 내지 8시간이 적절하고, 건조는 1차와 2차에 걸쳐서 행하여 급격한 건조에 따른 표면 경화 현상 및 홍삼 내에 함유된 다양한 향미 성분 및 휘발 가능한 약리활성 물질들의 휘발을 방지하는 것이 바람직할 것으로 보였다.From the above results, the temperature for red ginseng of red ginseng is 94-96 ° C., and the time for red ginseng is 5 to 8 hours, and drying is carried out over the first and second periods, so that the surface hardening phenomenon and the red ginseng are rapidly contained. It would be desirable to prevent volatilization of various flavor components and volatilizable pharmacologically active substances.
<< 실시예Example 1> 1>
본원발명의 홍삼 농축액의 제조Preparation of Red Ginseng Concentrate of the Invention
<1-1> 홍삼의 제조<1-1> Preparation of Red Ginseng
인삼(5년근 풍기인삼)을 물로 세척한 다음 세척한 인삼을 채반에 서로 눌리거나 겹치지 않도록 올려놓고, 94℃에서 6시간동안 증숙하였다. 증숙후, 제조기의 스팀을 서서히 배출시키거나 압력이 상압이 될 때까지 방치하였다. 이 때 갑자기 스팀을 빼면 삼의 몸체가 대부분이 터지게 되므로 주의한다. 증숙된 삼을 70℃의 열풍건조기에서 24시간 동안 건조한 후, 다시 50℃의 열풍건조기에서 72시간 동안 2차 건조를 실시하였다. 마지막으로 건조된 홍삼에서 지근과 세근 등을 다듬어 제품화를 하였다.The ginseng (5 years old Punggi ginseng) was washed with water, and the washed ginseng was placed on a rice tray so as not to be pressed or overlapped with each other, and steamed at 94 ° C. for 6 hours. After steaming, the steam of the machine was slowly discharged or left until the pressure became atmospheric pressure. At this time, if you suddenly remove steam, most of the body of hemp will burst. Steamed hemp was dried in a hot air dryer at 70 ° C. for 24 hours, and then again dried in a hot air dryer at 50 ° C. for 72 hours. Lastly, the dried red ginseng was trimmed to produce roots and roots.
<1-2> 홍삼 농축액의 제조<1-2> Preparation of Red Ginseng Concentrate
상기 실시예 <1-1>에서 제조된 홍삼을 원료로 하여 홍삼액 추출기를 이용해 홍삼농축액을 제조하였다. 건조된 홍삼에 20배량의 물을 가하고, 96℃에서 24시간동안 추출하였다. 여과하여 얻은 홍삼 추출액은 고형분이 약 2% 정도였고, 이것을 농축하여 고형분이 64%인 점성이 있는 홍삼 농축액을 제조하였다. Using red ginseng prepared in Example <1-1> as a raw material, a red ginseng concentrate was prepared using a red ginseng extractor. 20 times of water was added to the dried red ginseng and extracted at 96 ° C. for 24 hours. The red ginseng extract obtained by filtration was about 2% solids, and concentrated to prepare a red ginseng concentrate having a solid content of 64%.
<1-3> 상황 버섯 농축액의 제조<1-3> Preparation of Situation Mushroom Concentrate
상황 버섯을 원료로 추출기를 이용해 상황 농축액을 제조하였다. 절단된(3~4㎝×0.5~1㎝) 상황 버섯에 20배량의 물을 가하고, 100℃에서 3시간동안 추출하였다. 2차 추출은 상기의 과정과 동일한 방법 및 조건으로 실시하였다. 1차 및 2차 추출액은 여과하고 농축하여 고형분이 60%인 점성이 있는 상황버섯 농축액을 제조하였다. The situation concentrate was prepared using an extractor as a raw material of situation mushrooms. 20 times of water was added to the cut | disconnected (3-4 cm x 0.5-1 cm) situation mushroom, and it extracted at 100 degreeC for 3 hours. Secondary extraction was carried out in the same manner and conditions as the above procedure. The primary and secondary extracts were filtered and concentrated to prepare a viscous mushroom concentrate with a solid content of 60%.
<< 제조예Production Example 1> 1>
홍삼 Red ginseng 과립차의Granular tea 제조 Produce
상기 실시예 1에서 제조된 홍삼농축액(고형분 64%)을 이용하여 홍삼과립차를 제조하였다. 과립차의 제조는 향미를 부여하기 위해 허브엑기스(한미향료화학)을 사용하였다. 과립차 제조를 위해 사용한 홍삼농축액, 허브엑기스, 유당의 비율은 하기 표 3과 같다. Red ginseng granular tea was prepared using the red ginseng concentrate (64% solids) prepared in Example 1. Herbal extract (Hanmi Flavor Chemistry) was used to prepare granule tea. Red ginseng concentrate, herbal extracts, lactose ratio used for the production of granular tea is shown in Table 3 below.
과립차의 제조 공정은 다음과 같다. ① 혼합: 상기 각각의 원료를 배합비율에 따라 넣은 뒤, 더블 콘 믹서(double cone mixer)에서 20분간 혼합하였다. ② 연합: 혼합물 무게 대비 정제수를 10%정도 첨가하고, 믹서에서 20분간 연합을 실시하였다. ③ 과립: 연합물을 오실레이터(oscillator)에서 체를 통과시켰다. ④ 건조: 과립물을 60℃의 건조기에서 15시간 건조하였다. 건조는 수분함량이 5%이하가 될 때까지 실시하였다. ⑤ 정립: 건조물을 오실레이터에서 체를 통과시켰다. ⑥ 충진: 과립 차 포장을 위해 충진기로 충진하였다.The manufacturing process of granule tea is as follows. ① Mixing: Each of the above raw materials was added according to the mixing ratio, and mixed for 20 minutes in a double cone mixer. ② Association: 10% of purified water was added to the mixture, and 20 minutes were combined in a mixer. ③ Granules: The association was passed through a sieve in the oscillator (oscillator). ④ Drying: The granules were dried in a dryer at 60 ° C. for 15 hours. Drying was carried out until the moisture content was 5% or less. ⑤ Formulation: The dried material was passed through a sieve in the oscillator. ⑥ Filling: Filled with filler for packing granular tea.
상기의 배합비로 제조된 과립차의 관능 및 성상(과립차의 외관적 형태, 용해성, 향기 등)을 검사한 결과 홍삼엑기스 8%, 허브엑기스 2%, 유당 90%의 경우가 좋은 것으로 나타났다. As a result of examining the sensory properties and properties (granular tea appearance, solubility, fragrance, etc.) of the granulated tea prepared at the blending ratio, 8% red ginseng extract, 2% herbal extract, and 90% lactose were good.
<< 제조예Production Example 2> 2>
홍삼-상황 Red Ginseng-Situation 과립차의Granular tea 제조 Produce
상기 실시예 1에서 제조한 홍삼농축액(고형분 64%)과 상황농축액(고형분 60%)을 이용하여 홍삼-상황 과립차를 제조하였다. 과립차의 제조는 향미를 부여하기 위해 허브향을 사용하였으며, 홍삼농축액, 상황농축액, 허브엑기스, 유당의 비율은 하기 표 4와 같다. Red ginseng-sulfur granule tea was prepared using the red ginseng concentrate (64% solids) and the situation concentrate (60% solids) prepared in Example 1. In the preparation of granular tea was used herb flavor to give the flavor, the ratio of red ginseng concentrate, situation concentrate, herbal extract, lactose is shown in Table 4.
과립차의 제조공정은 다음과 같다. ① 혼합: 상기 각각의 원료를 배합비율에 따라 넣은 뒤, 더블 콘 믹서(double cone mixer)에서 20분간 혼합하였다. ② 연합: 혼합물 무게 대비 정제수를 10%정도 첨가하고, 믹서에서 20분간 연합을 실시하였다. ③ 과립: 연합물을 오실레이터(oscillator)에서 체를 통과시켰다. ④ 건조: 과립물을 60℃의 건조기에서 15시간 건조하였다. 건조는 수분함량이 5%이하가 될 때까지 실시하였다. ⑤ 정립: 건조물을 오실레이터에서 체를 통과시켰다. ⑥ 충진: 과립 차 포장을 위해 충진기로 충진하였다.The manufacturing process of granule tea is as follows. ① Mixing: Each of the above raw materials was added according to the mixing ratio, and mixed for 20 minutes in a double cone mixer. ② Association: 10% of purified water was added to the mixture, and 20 minutes were combined in a mixer. ③ Granules: The association was passed through a sieve in the oscillator (oscillator). ④ Drying: The granules were dried in a dryer at 60 ° C. for 15 hours. Drying was carried out until the moisture content was 5% or less. ⑤ Formulation: The dried material was passed through a sieve in the oscillator. ⑥ Filling: Filled with filler for packing granular tea.
상기의 배합비로 제조된 과립차의 관능 및 성상(과립차의 외관적 형태, 용해성, 향기 등)을 검사한 결과 홍삼엑기스 8%, 상황엑기스 1%, 허브엑기스 1%, 유당 89%의 경우가 가장 좋은 것으로 나타났다. The results of the sensory and properties (granular tea appearance, solubility, fragrance, etc.) of the granulated tea prepared at the above compounding ratio were the best for red ginseng extract 8%, situation extract 1%, herbal extract 1%, and lactose 89%. Appeared.
<< 제조예Production Example 3> 3>
홍삼-상황 캅셀의 제조Preparation of Red Ginseng-Situation Capsules
홍삼과 상황을 휴대용으로 복용이 가능하도록 캅셀(capsule) 형태의 제제로 제조하기 위하여 하기 표 5와 같은 배합비를 이용하여 다음의 공정으로 홍삼-상황 캅셀을 제조하였다. In order to prepare a red ginseng and the situation in the form of a capsule (capsule) in order to be able to take a portable red ginseng-sense capsule was prepared by the following process using a compounding ratio as shown in Table 5.
① 혼합: 상기의 원료를 배합비율에 따라 넣은 후 더블 콘 믹서(double cone mixer)를 이용하여 20분동안 혼합하였다. ② 충진: 자동 또는 반자동 캅셀 충진기로 충진하였다(330mg). ③ 선별: 공 캅셀 및 불량품을 선별하여 제품화를 하였다. ① Mixing: The raw materials were added according to the mixing ratio and mixed for 20 minutes using a double cone mixer. ② Filling: Filled with automatic or semi-automatic capsule filling machine (330mg). ③ Selection: Empty capsules and defective products were selected and commercialized.
상기의 배합비로 제조된 과립차의 관능 및 성상(과립차의 외관적 형태, 용해성, 향기 등)을 검사한 결과 홍삼엑기스 10%, 상황균사분말 5%, 아비셀 80%, 비타민 B1 0.1%, 비타민 B6 0.1%, L-아르기닌 2.4%, 타우린 2.4%의 경우가 좋은 것으로 나타났다. The results of testing the sensory properties and properties (granular tea appearance, solubility, fragrance, etc.) of the granulated tea prepared at the above compounding ratio were 10% red ginseng extract, 5% situational mycelial powder, 80% Avicel, 0.1% vitamin B1, and vitamin B6 0.1. %, L-arginine 2.4%, taurine 2.4% was good.
<< 제조예Production Example 4> 4>
홍삼-상황 Red Ginseng-Situation 타블렛의Tablet 제조 Produce
홍삼과 상황을 휴대용으로 복용이 가능하도록 타블렛(tablet) 형태의 제제로 제조하기 위하여 상기 표 5와 같은 배합비를 이용하여 다음의 공정으로 홍삼-상황 타블렛을 제조하였다. In order to prepare the red ginseng and the situation in a tablet (tablet) form to be taken in a portable formulation, the red ginseng-situation tablet was prepared by the following process using the compounding ratio as shown in Table 5.
홍삼-상황 타블렛 제조공정으로는 ① 분쇄: 상황균사체 추출물 분말을 분쇄 하였다(80mesh 이하). ② 혼합: 상기의 원료를 배합비율에 따라 첨가하여 혼합하였다. ③ 연합: 혼합물에 50% EtOH 3%(v/w)를 첨가하여 믹서에서 20분간 연합을 실시하였다. ④ 과립: 연합물을 오실레이터(oscillator)에서 체(20mesh)를 통과시켰다. ⑤ 건조: 과립물을 55℃의 건조기에서 5시간 동안 건조하였다. ⑥ 정립: 건조물을 오실레이터에서 체(20mesh)를 통과시킨다. ⑦ 타정: 개개의 정제를 타정하여(500mg) 타블렛을 제조하였다.Red ginseng-situation tablet manufacturing process ① grinding: ground mycelium extract powder was ground (less than 80mesh). ② Mixing: The above raw materials were added and mixed according to the blending ratio. ③ Association: Addition of 50% EtOH 3% (v / w) to the mixture was performed for 20 minutes in a mixer. ④ Granules: The association was passed through a sieve (20mesh) in an oscillator (oscillator). ⑤ Drying: The granules were dried in a dryer at 55 ° C. for 5 hours. ⑥ Formulation: Pass the dried material through a sieve (20mesh) in the oscillator. ⑦ Tableting: Tablets were prepared by tableting individual tablets (500 mg).
<< 제조예Production Example 5> 5>
홍삼-동충하초 Red Ginseng-Cordyceps sinensis 드링크의Drink 제조 Produce
상기 실시예 1에서 제조한 홍삼 농축액 및 동충하초 농축액이 포함된 드링크를 제조하기 위하여 다음과 같이 실시하였다.To prepare a drink containing the red ginseng concentrate and Cordyceps sinensis concentrate prepared in Example 1 was carried out as follows.
이 때 동충하초 추출액은 동충하초 4g(0.2g/병×20병)을 추출용기에 넣고, 물을 30배(120ml)가하고, 100℃에서 60분간 추출하였다. 이 추출액은 5㎛의 여과지(No. 2)로 여과하여 여과액을 얻었다.At this time, the Cordyceps sinensis extract was placed in an extract container of Cordyceps sinensis 4g (0.2g / bottle x 20 bottles), 30 times (120ml) of water, and extracted at 100 ℃ 60 minutes. This extract was filtered with a 5 μm filter paper (No. 2) to obtain a filtrate.
시험연구(20병-2,000ml)를 위해 액상과당 260g에 정제수 1,000ml를 가하고, 90 내지 95℃에서 30분 정도 용해 및 예비 살균을 실시하였다. 이것을 60 내지 70℃로 냉각시킨 후, 하기 표 6의 조성에 따라 산미료, 기능성원료, 보존료, 조미료, 착색료, 비타민 순으로 첨가하여 혼합기를 이용하여 혼합 및 용해시켰다.For a test study (20 bottles-2,000 ml), 1,000 ml of purified water was added to 260 g of liquid fructose, and dissolved and pre-sterilized for 30 minutes at 90 to 95 ° C. After cooling to 60 to 70 ℃, according to the composition of Table 6, acidulants, functional ingredients, preservatives, seasonings, coloring, vitamins were added in order and mixed and dissolved using a mixer.
상기의 방법들을 이용하여 제조한 성분들을 하기 표 6의 조성에 따라 홍삼-동충하초 음료를 대량 제조하여 각각 100ml씩 병입하고 뚜껑을 덮어 밀봉기를 이용하여 밀봉한 후, 80℃의 수욕상에서 15 내지 30분간 살균을 실시하여 제조하였다.According to the composition of Table 6, the ingredients prepared using the above methods were prepared in large quantities by red ginseng-Congdongchaecho drink, each bottle 100ml and sealed with a sealer, and then sealed with a sealer for 15 to 30 minutes in an 80 ° C water bath. Prepared by sterilization.
<< 제조예Production Example 6> 6>
홍삼-상황버섯 Red Ginseng 드링크의Drink 제조 Produce
상기 실시예 1에서 제조한 홍삼 농축액 및 상황버섯 농축액이 포함된 드링크를 제조하기 위하여 다음과 같이 실시하였다.To prepare a drink containing the red ginseng concentrate and the situation mushroom concentrate prepared in Example 1 was carried out as follows.
이 때 상황버섯 추출액은 다음과 같이 제조하였다. 상황버섯 2g(0.1g/병×20병=2g)을 추출용기에 넣고, 물을 30배(60ml) 가하고, 100℃에서 60분간 추출하였다. 이 추출액은 5㎛의 여과지(No 2)로 여과하여 여과액을 얻었다. At this time, the situation mushroom extract was prepared as follows. 2 g (0.1 g / bottle x 20 bottles = 2 g) of mushrooms were placed in an extraction container, 30 times (60 ml) of water was added, and the mixture was extracted at 100 ° C for 60 minutes. This extract was filtered with a 5 μm filter paper (No 2) to obtain a filtrate.
시험연구(20병-2,000ml)를 위해 백당 280g에 정제수 1,000ml를 가하고, 90 내지 95℃에서 30분 정도 용해 및 예비 살균을 실시하였다. 이것을 60 내지 70℃로 냉각시킨 후, 하기 표 7의 조성에 따라 산미료, 기능성원료, 보존료, 조미료, 착색료, 비타민 순으로 첨가하여 혼합기를 이용하여 혼합 및 용해시켰다.For a test study (20 bottles-2,000 ml), 1,000 ml of purified water was added to 280 g per bag, and dissolution and pre-sterilization were performed at 90 to 95 ° C for about 30 minutes. After cooling it to 60-70 degreeC, it added in order of acidulant, functional raw material, preservative, seasoning, coloring, and vitamin according to the composition of Table 7, and mixed and melt | dissolved using the mixer.
상기의 방법들을 이용하여 제조한 성분들을 하기 표 7의 조성에 따라 홍삼-상황버섯 음료를 대량 제조하여 각각 100ml씩 병입하고, 뚜껑을 덮어 밀봉기를 이용하여 밀봉한 후, 80℃의 수욕상에서 15 내지 30분간 살균을 실시하여 제조하였다.According to the composition of Table 7, the ingredients prepared using the above methods were prepared in large quantities by red ginseng-situation mushroom drink, each bottle 100ml, sealed with a sealer, and then 15 to 80 ° C. in a water bath. Prepared by sterilization for 30 minutes.
상술한 바와 같이, 본 발명에 따른 홍삼 농축액의 제조방법은 조사포닌 함량이 우수한 홍삼 농축액을 제조할 수 있게 한다. 따라서, 본 발명의 제조방법에 의해 제조된 홍삼 농축액은 효능이 뛰어난 홍삼 관련 제품을 제조할 수 있게 할 뿐만 아니라 상황 버섯, 동충하초와 더불어 우수한 홍삼 관련 제품의 제조에 이용될 수 있다.As described above, the manufacturing method of the red ginseng concentrate according to the present invention enables to prepare a red ginseng concentrate having a high content of irradiated saponins. Therefore, the red ginseng concentrate prepared by the manufacturing method of the present invention can be used not only to produce a red ginseng-related product having excellent efficacy, but also to prepare excellent red ginseng-related products along with mushrooms and cordyceps.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070056322A KR100921266B1 (en) | 2007-06-08 | 2007-06-08 | Manufacturing method of red ginseng concentrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020070056322A KR100921266B1 (en) | 2007-06-08 | 2007-06-08 | Manufacturing method of red ginseng concentrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20080107924A true KR20080107924A (en) | 2008-12-11 |
| KR100921266B1 KR100921266B1 (en) | 2009-10-09 |
Family
ID=40368059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020070056322A Expired - Fee Related KR100921266B1 (en) | 2007-06-08 | 2007-06-08 | Manufacturing method of red ginseng concentrate |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100921266B1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103156188A (en) * | 2011-12-15 | 2013-06-19 | 上海奥医高科技实业有限公司 | Health food with function of immune regulation and hypoxia tolerance |
| KR101358755B1 (en) * | 2012-08-20 | 2014-02-07 | 곽병렬 | Manufacturing method of red ginseng and red ginseng from the same |
| US20140050805A1 (en) * | 2011-04-15 | 2014-02-20 | Lion Corporation | Composition, glucose metabolism-improving agent, and method for improving glucose metabolism |
| WO2020075897A1 (en) * | 2018-10-11 | 2020-04-16 | 태웅식품 주식회사 | Method of preparing beverage comprising whole ginseng |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101969408B1 (en) | 2017-12-29 | 2019-04-16 | 대한민국 | Ginseng extract processing room for reducing the harmful substances |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010038802A (en) * | 1999-10-27 | 2001-05-15 | 박명규 | Manufacturing for Preparing the High Quality Red Ginseng |
| KR100730647B1 (en) * | 2005-06-17 | 2007-06-20 | (주)김가고려인삼 | Aged red ginseng concentrate and preparation method thereof |
| KR20060108268A (en) * | 2006-09-27 | 2006-10-17 | 주식회사 서울식연 | Preparation method and antioxidant of red ginseng |
-
2007
- 2007-06-08 KR KR1020070056322A patent/KR100921266B1/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140050805A1 (en) * | 2011-04-15 | 2014-02-20 | Lion Corporation | Composition, glucose metabolism-improving agent, and method for improving glucose metabolism |
| KR20140021598A (en) * | 2011-04-15 | 2014-02-20 | 라이온 가부시키가이샤 | Composition, glucose metabolism-improving agent, and method for improving glucose metabolism |
| EP2698161A4 (en) * | 2011-04-15 | 2014-08-27 | Lion Corp | COMPOSITION, AGENT ENHANCING GLUCOSE METABOLISM, AND METHOD FOR ENHANCING GLUCOSE METABOLISM |
| CN103156188A (en) * | 2011-12-15 | 2013-06-19 | 上海奥医高科技实业有限公司 | Health food with function of immune regulation and hypoxia tolerance |
| KR101358755B1 (en) * | 2012-08-20 | 2014-02-07 | 곽병렬 | Manufacturing method of red ginseng and red ginseng from the same |
| WO2020075897A1 (en) * | 2018-10-11 | 2020-04-16 | 태웅식품 주식회사 | Method of preparing beverage comprising whole ginseng |
Also Published As
| Publication number | Publication date |
|---|---|
| KR100921266B1 (en) | 2009-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100913243B1 (en) | Hangover drink composition | |
| CN112121144B (en) | Roxburgh rose composition and preparation method and application thereof | |
| KR101870940B1 (en) | health food composition for improving andropause syndrome | |
| KR101392204B1 (en) | Composition comprising herbal extract of red ginseng, Angelicae gigantis Radix, citrus peel and green tea leaves for treating or preventing vascular diseases | |
| KR100921266B1 (en) | Manufacturing method of red ginseng concentrate | |
| KR100982434B1 (en) | Method for extracting natural substance using sucrose aqueous solution, composition including the same and functional food employing the same | |
| KR100730647B1 (en) | Aged red ginseng concentrate and preparation method thereof | |
| KR101915031B1 (en) | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts | |
| KR102505329B1 (en) | Method for producing processed red ginseng food using material having improvement effect of cognitive function | |
| KR101534554B1 (en) | Beverage for improving gynecologic disorders | |
| KR101788253B1 (en) | Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic | |
| KR20100130020A (en) | Composition containing black ginseng and extracts thereof prepared by a novel manufacturing method that does not contain carcinogenic substances such as benzopyran | |
| KR101409168B1 (en) | Method for manufacturing red ginseng extract with enhanced function and the extact thereof | |
| KR101962169B1 (en) | Manufacturing method of an extract enriched with ginsenoside Rg3 from red ginseng and food composition containing it | |
| KR102698223B1 (en) | Method for preparing leaf tea of Gynostemma pentaphyllum and method for preparing Gynostemma pentaphyllum extracts using the leaf tea prepared thereby | |
| CN109287916A (en) | A kind of preparation method of Sessileflower Acanthopanax Bark extracting solution and its beverage | |
| CN108497246A (en) | A kind of plant weight losing function beverage and preparation method thereof | |
| KR20130067507A (en) | A composition comprising the extract of combined herb of panax ginseng and vitis genus plant treating and preventing neuro-degenerative disease and enhancing memory power | |
| KR101381277B1 (en) | The wild rice gel containing ginseng | |
| KR101097664B1 (en) | Method of processing roots of korea ginseng | |
| KR102698224B1 (en) | Method for preparing leaf tea of Gynostemma pentaphyllum using fresh leaf and method for preparing Gynostemma pentaphyllum extracts using the leaf tea prepared thereby | |
| KR102679206B1 (en) | Composition for treating, preventing, or improving symptoms of stroke, including complex herbal extracts as active ingredients | |
| KR20120033443A (en) | Antifatigue composition comprising the extracts, fractions or isolated compounds of eisenia bicyclis and process for preparation thereof | |
| KR102818204B1 (en) | Method for Producing Red Ginseng Concentrate with Enhanced Red Ginseng Function | |
| CN104431670A (en) | Red date and apple jam and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R15-X000 | Change to inventor requested |
St.27 status event code: A-3-3-R10-R15-oth-X000 |
|
| R16-X000 | Change to inventor recorded |
St.27 status event code: A-3-3-R10-R16-oth-X000 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| D14-X000 | Search report completed |
St.27 status event code: A-1-2-D10-D14-srh-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| J201 | Request for trial against refusal decision | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PJ0201 | Trial against decision of rejection |
St.27 status event code: A-3-3-V10-V11-apl-PJ0201 |
|
| E701 | Decision to grant or registration of patent right | ||
| PB0901 | Examination by re-examination before a trial |
St.27 status event code: A-6-3-E10-E12-rex-PB0901 |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| FPAY | Annual fee payment |
Payment date: 20121005 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| FPAY | Annual fee payment |
Payment date: 20131007 Year of fee payment: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20141006 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20151005 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20161006 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20161006 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |